Increased activation of the neuroinflammatory response was observed in vivo and in vitro, thereby suggesting BMAL1 may have a neuroprotective effect in the depletion of dopaminergic neurons and disrupted BMAL1 may accelerate PD pathology (Liu et al., 2020). Here, BMAL1 is linked to Parkinson disease.